Chief Commercial Officer
LeRoux is a Pharma/Biotech executive with with global experience in senior leadership positions responsible for driving commercial performance. Most recently he served as Chief Commercial Officer and Senior Vice President Business Development at Ocata Therapeutics. He previously held executive positions at Antares Pharma, Cephalon, Wyeth and Eli Lilly. LeRoux has led the commercialization and launch of several innovative products including Enbrel™, Otrexup™ and Prozac™. He graduated from Pharmacy School and obtained his Bachelor of Commerce degree in South Africa.